SAN FRANCISCO, March 07, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, alerts investors of the March 14, 2016, lead plaintiff deadline in the securities fraud class action lawsuit against Natural Health Trends Corporation (NASDAQ:NHTC) related to the recent plunge in the Company’s share price. Natural Health Trends is under investigation by the Beijing Chaoyang District SAIC and the Chinese Public Security Bureau.
If you suffered losses because of your purchases of Natural Health Trends securities between March 6, 2015 and January 12, 2016, contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation by calling 510-725-3000, emailing [email protected] or visiting https://www.hbsslaw.com/cases/NHTC. The lawsuit was filed in the U.S. District Court for the Central District of California and investors have until March 14, 2016 to move the court to participate as a lead plaintiff.
Natural Health Trends operates as an international direct-selling and e-commerce company, and controls wholly-owned subsidiaries that have an active presence in North America, China, South Korea, Japan, and Europe. In China, the Company sells directly to consumers through its e-commerce platform.
On January 7, 2016, Seeking Alpha reported that the Company is under investigation by Chinese authorities. On this news, shares of Natural Health Trends fell $3.11 per share or over 10% from its previous closing price to close at $25.92 per share on January 7, 2016.
Then, on January 11 and 12, 2016, analyst firm GeoInvesting LLC issued two reports about the Company that corroborated earlier reports about the investigation, even though Natural Health Trends denied knowledge of any such investigation. On these two days, the stock dropped again, dropping $2.65 per share, over 11%, on January 11, 2016 and an additional $1.51 per share, or over 7%, to close at $19.18 per share on January 12, 2016.
“While the stock’s recent drop relates only to the Chinese investigation, we continue to investigate the sudden slip starting around late December,” said Hagens Berman partner Reed Kathrein. “Often such a decline, on no discernable publicly reported news, means insiders or others are bailing out on anticipated news not shared with the public.”
Whistleblowers: Persons with non-public information regarding Natural Health Trends in the United States or China should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 510-725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 



